F Dx Advisors, Inc. Galapagos Nv Transaction History

F Dx Advisors, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$68.86 - $83.34 $292,448 - $353,944	-4,247 Closed	0 $0
Q1 2021 Apr 14, 2021	BUY	$76.15 - $111.94 $298,508 - $438,804	3,920 Added 1198.78%	4,247 $327,000
Q1 2021 Apr 13, 2021	SELL	$76.15 - $111.94 $291,654 - $428,730	-3,830 Reduced 92.13%	327 $25,000
Q4 2020 Feb 08, 2021	BUY	$96.85 - $148.25 $83,581 - $127,939	863 Added 26.2%	4,157 $411,000
Q3 2020 Nov 12, 2020	BUY	$122.47 - $213.56 $612 - $1,067	5 Added 0.15%	3,294 $467,000
Q2 2020 Jul 22, 2020	BUY	$185.52 - $231.25 $138,583 - $172,743	747 Added 29.39%	3,289 $649,000
Q1 2020 May 22, 2020	BUY	$143.0 - $274.03 $363,506 - $696,584	2,542 New	2,542 $498,000
Q1 2020 May 13, 2020	SELL	$143.0 - $274.03 $421,421 - $807,566	-2,947 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$146.12 - $215.82 $4,675 - $6,906	32 Added 1.1%	2,947 $610,000
Q3 2019 Nov 07, 2019	BUY	$130.44 - $187.64 $99,264 - $142,794	761 Added 35.33%	2,915 $445,000
Q2 2019 Jul 19, 2019	BUY	$111.45 - $128.93 $12,816 - $14,826	115 Added 5.64%	2,154 $278,000
Q1 2019 May 14, 2019	BUY	$89.61 - $117.78 $182,714 - $240,153	2,039 New	2,039 $240,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.84B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on F Dx Advisors, Inc. with notifications on news.